Prospecting insights for medtech regulatory firms

Practical field notes on finding Chinese manufacturers at the right moment · Updated 2026-08-13

Fresh NMPA Filings Are the Strongest Timing Signal for FDA U.S. Agents. Here's Why. Why registrant databases are too late, and how NMPA filing activity reveals the calling window before export decisions are made.

How EU Authorised Representatives Find Chinese Manufacturers Before Their Competitors Do EUDAMED is live. Here's the export-ready profile to look for and the outreach angle that works.

The 5-Minute Lead Audit: Three NMPA Signals Any Regulatory Firm Can Read Today Recency, export identity, and FDA cross-match - a fast audit you can run on any Chinese manufacturer.

Provenance Beats "Verified Leads": Why Source Links Matter in Sales Intelligence Three things every lead must prove, and why your reputation depends on auditability.

A $49 Test That Tells You If a New Market Segment Is Worth Your Team's Time A cheap, measurable way to validate a new service line - before you spend your team's weekends.

Want the shortlist instead of the manual work? 10 companies at USD 49 or the full current release at USD 99, selected for your buyer segment, with business emails, websites, registration references, confidence grades, and source links included.

See the packs Download the 3-company sample (XLSX)